#xf73 - Twitter Hashtag

about 2 years ago

New data on Destiny's lead drug, XF-73, has been accepted for presentation at the Infection Prevention Society conference in September 2024. To read the press release, click on link below https://t.co/UsYCEeyMdn #DEST #XF73 #IP2024

1

2

0

351

Destiny Pharma @DestinyPharma

over 2 years ago

PEW Charitable Trust raises awareness of the urgent need for new antibiotics. Destiny’s lead candidate, XF-73, is addressing this need. https://t.co/UOc4pfnpiS #PEW #DEST #XF73 #AMR

1

5

1

0

439

Destiny Pharma @DestinyPharma

almost 3 years ago

Destiny Pharma is holding its XF Pipeline Update meeting, for analysts and investors, today at 1400 BST / 0900 EDT. It’s not too late to join the meeting virtually, please register via the link below:- https://t.co/eqabM3QBgR #DEST #XF73

0

6

2

0

571

Destiny Pharma @DestinyPharma

about 3 years ago

Destiny’s CSO, Dr Bill Love, speaks to @Pharmaphorum for their article ‘Experts warn of superbug risks after Madonna’s hospitalisation’. To read the full article, follow the link below:- https://t.co/3j1d4GYWAN #DEST #XF73

0

5

2

0

690

Destiny Pharma @DestinyPharma

over 3 years ago

Another new Destiny Pharma animation! This time we explain the healthcare significant benefits of using our XF-73 nasal gel to prevent post-surgical infections. Click on the link to view:- https://t.co/6aycKze8zW #DEST #XF73

0

8

4

0

820

Destiny Pharma @DestinyPharma

over 3 years ago

Destiny's CEO, Neil Clark, speaks to Vox Markets on Landmark XF-73 Phase 2 data published in US peer reviewed journal #DEST #XF73

0

2

1

0

880

Destiny Pharma @DestinyPharma

almost 4 years ago

Destiny Pharma’s XF-73 program to prevent post-surgical infections features in Professor Alex Mericli's talk on Surgical Site Infection in Implant-Based Breast Reconstruction at the recent R&D Investor Update. Click below to view:- https://t.co/MvRPEiTXI4 #DEST #XF73 #SSI #AMR

0

2

0

Destiny Pharma @DestinyPharma

about 4 years ago

US CDC report shows 'alarming increase in resistant infections' with hospital related infections due to MRSA growing by 13% in 2020 due to COVID-19. Destiny Pharma’s drug XF-73 is aimed at reducing post-surgery MRSA and resistance (AMR). https://t.co/h0NbjP52me #AMR #MRSA #XF73

0

5

3

0

Destiny Pharma @DestinyPharma

about 4 years ago

@DestinyPharma announces new cystic fibrosis research award from the @CF_Foundation . The project will investigate the potential of XF-73 as a novel treatment for cystic fibrosis patients infected with MRSA. Read more: https://t.co/vLXBjA0RKB #XF73 #CF #MRSA

0

5

3

0

Destiny Pharma @DestinyPharma

almost 5 years ago

@DestinyPharma's XF-73 Dermal Programme featured in presentation by Dr Phil Packer (@innovateuk) at today’s @WHFEvents: Tackling antimicrobial resistance in the UK and the UK’s role on the global stage #WHFevents #AMR #biotech #XF73

DestinyPharma's tweet photo. @DestinyPharma's XF-73 Dermal Programme featured in presentation by Dr Phil Packer (@innovateuk) at today’s @WHFEvents: Tackling antimicrobial resistance in the UK and the UK’s role on the global stage
#WHFevents #AMR #biotech #XF73 https://t.co/gNoi0Ug1eR

0

3

0

OptimumComms

@OptimumComms

about 5 years ago

@DestinyPharma today announces a Company update on secondary endpoint analysis from recent positive Phase 2b trial Read more: https://t.co/aJnX8iO22i #XF73 #AMR #biotech #postsurgicalinfections

Destiny Pharma @DestinyPharma

about 5 years ago

.@DestinyPharma provides update on secondary endpoint analysis from recent positive Phase 2b trial https://t.co/ZZaxJhECzY #XF73 #AMR #biotech #postsurgicalinfections

0

5

2

0

2

0

Destiny Pharma @DestinyPharma

about 5 years ago

.@DestinyPharma provides update on secondary endpoint analysis from recent positive Phase 2b trial https://t.co/ZZaxJhECzY #XF73 #AMR #biotech #postsurgicalinfections

0

5

2

0

Destiny Pharma @DestinyPharma

over 5 years ago

Destiny Pharma announces that Neil Clark & Shaun Claydon to provide a live presentation relating to Full Year Results for y/e 31 December 2020 on 22 April 2021 at 1400 BST. Click on link below for more info https://t.co/trAD2oFL24 #XF73 #AMR #biotech #postsurgicalinfections $DEST

0

2

1

0

Destiny Pharma @DestinyPharma

over 5 years ago

Our CEO, Neil Clark, talks to #ProactiveInvestors about the financial results for the year ended 31 December 2020 #XF73 #AMR #biotech #postsurgicalinfections $DEST

Proactive

@proactive_x

over 5 years ago

$DEST Destiny Pharma says 'we had a very strong 2020 which carried on into 2021 Q1' https://t.co/HHXVwnHGNE @destinypharma #DEST #Katie_Proactive

0

1

0

3

1

0

Destiny Pharma @DestinyPharma

over 5 years ago

.@DestinyPharma joined a presentation with Equity Development to discuss Monday's positive Phase 2b Results, watch the interview here: https://t.co/3kT2MPHO2R #XF73 #AMR #biotech #postsurgicalinfections

0

3

1

0

Destiny Pharma @DestinyPharma

over 5 years ago

Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel. See the data here: https://t.co/foQ6CqOC3T #XF73 #AMR #postsurgicalinfections

0

16

4

0

Gambit @AIM_Gambit

over 5 years ago

1/ $DEST UPDATE $DEST.L #XF73 Phase 2b recruitment complete, results in next few weeks Successfully Phase 2a results already published At £45m MCap, #DEST is a Pharma Biotech Plc with huge upside potential Today FinnCap set 380p target (currently 75p) https://t.co/ESVI3SVGM2

1

5

0

Destiny Pharma @DestinyPharma

almost 6 years ago

Destiny Pharma is supporting World Antimicrobial Resistance (#AMR) Awareness Week #WAAW #XF73 #antibacterial #immunology

DestinyPharma's tweet photo. Destiny Pharma is supporting World Antimicrobial Resistance (#AMR) Awareness Week
#WAAW #XF73 #antibacterial #immunology https://t.co/T2e7NljBcy

0

7

3

0

Top Tweets for #xf73

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users